Gamma-aminobutyric acid: Difference between revisions
No edit summary |
No edit summary |
||
| Line 34: | Line 34: | ||
|warnings=* WARNINGS: If [[pregnant]] or [[breast-feeding]], ask a health professional before use. | |warnings=* WARNINGS: If [[pregnant]] or [[breast-feeding]], ask a health professional before use. | ||
|clinicalTrials=There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label. | |clinicalTrials=There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label. | ||
|postmarketing=* Visual defects with vigabatrin administration | |postmarketing=* Visual defects with vigabatrin administration. | ||
* [[Flushing]], [[euphoria]], [[anxiety]] | * [[Flushing]], [[euphoria]], [[anxiety]]. | ||
* Increased [[blood pressure]] and [[heart rate]] | * Increased [[blood pressure]] and [[heart rate]]. | ||
|drugInteractions= | |drugInteractions=<!--Use in Specific Populations--> | ||
<!--Use in Specific Populations--> | |||
|useInPregnancyFDA=* '''Pregnancy Category''' | |useInPregnancyFDA=* '''Pregnancy Category''' | ||
|useInPregnancyAUS=* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category''' | |useInPregnancyAUS=* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category''' | ||
| Line 64: | Line 63: | ||
<!--Overdosage--> | <!--Overdosage--> | ||
|overdose= | |overdose=There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label. | ||
There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label. | |||
<!--Pharmacology--> | <!--Pharmacology--> | ||
| Line 71: | Line 69: | ||
<!--Drug box 2--> | <!--Drug box 2--> | ||
|drugBox=<!--Mechanism of Action--> | |drugBox=<!--Mechanism of Action--> | ||
|mechAction= | |mechAction=<!--Structure--> | ||
<!--Structure--> | |||
|structure=* | |structure=* | ||
Revision as of 20:26, 3 April 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Overview
Gamma-aminobutyric acid is an anxiolytic that is FDA approved for the treatment of epilepsy. Common adverse reactions include hypersensitivity.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
- Adults and children 5 to 10 drops orally, 1 time daily or as otherwise directed by a health care professional. If symptoms persist, consult your health care professional. * Consult a physician for use in children under 12 years of age.
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Gamma-aminobutyric acid in adult patients.
Non–Guideline-Supported Use
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
There is limited information regarding FDA-Labeled Use of Gamma-aminobutyric acid in pediatric patients.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Gamma-aminobutyric acid in pediatric patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Gamma-aminobutyric acid in pediatric patients.
Contraindications
Warnings
- WARNINGS: If pregnant or breast-feeding, ask a health professional before use.
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Clinical Trial Experience of Gamma-aminobutyric acid in the drug label.
Postmarketing Experience
- Visual defects with vigabatrin administration.
- Flushing, euphoria, anxiety.
- Increased blood pressure and heart rate.
Drug Interactions
There is limited information regarding Gamma-aminobutyric acid Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
- Pregnancy Category
- Australian Drug Evaluation Committee (ADEC) Pregnancy Category
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Gamma-aminobutyric acid in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Gamma-aminobutyric acid during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Gamma-aminobutyric acid with respect to nursing mothers.
Pediatric Use
There is no FDA guidance on the use of Gamma-aminobutyric acid with respect to pediatric patients.
Geriatic Use
There is no FDA guidance on the use of Gamma-aminobutyric acid with respect to geriatric patients.
Gender
There is no FDA guidance on the use of Gamma-aminobutyric acid with respect to specific gender populations.
Race
There is no FDA guidance on the use of Gamma-aminobutyric acid with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Gamma-aminobutyric acid in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Gamma-aminobutyric acid in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Gamma-aminobutyric acid in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Gamma-aminobutyric acid in patients who are immunocompromised.
Administration and Monitoring
Administration
Monitoring
There is limited information regarding Monitoring of Gamma-aminobutyric acid in the drug label.
IV Compatibility
There is limited information regarding IV Compatibility of Gamma-aminobutyric acid in the drug label.
Overdosage
There is limited information regarding Chronic Overdose of Gamma-aminobutyric acid in the drug label.
Pharmacology
There is limited information regarding Gamma-aminobutyric acid Pharmacology in the drug label.
Mechanism of Action
There is limited information regarding Gamma-aminobutyric acid Mechanism of Action in the drug label.
Structure
File:Gamma-aminobutyric acid01.png This image is provided by the National Library of Medicine.
Pharmacodynamics
There is limited information regarding Pharmacodynamics of Gamma-aminobutyric acid in the drug label.
Pharmacokinetics
There is limited information regarding Pharmacokinetics of Gamma-aminobutyric acid in the drug label.
Nonclinical Toxicology
There is limited information regarding Nonclinical Toxicology of Gamma-aminobutyric acid in the drug label.
Clinical Studies
There is limited information regarding Clinical Studies of Gamma-aminobutyric acid in the drug label.
How Supplied
There is limited information regarding Gamma-aminobutyric acid How Supplied in the drug label.
Storage
There is limited information regarding Gamma-aminobutyric acid Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Gamma-aminobutyric acid |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Gamma-aminobutyric acid |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Patient Counseling Information of Gamma-aminobutyric acid in the drug label.
Precautions with Alcohol
- Alcohol-Gamma-aminobutyric acid interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
- GABA PHENOLIC ®[1]
Look-Alike Drug Names
There is limited information regarding Gamma-aminobutyric acid Look-Alike Drug Names in the drug label.
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.
{{#subobject:
|Label Page=Gamma-aminobutyric acid |Label Name=GABA 01.jpg
}}
{{#subobject:
|Label Page=Gamma-aminobutyric acid |Label Name=DailyMed - GABA PHENOLIC - .gamma.-aminobutyric acid liquid .png
}}
}}